Relacorilant combined with nab-paclitaxel (Abraxane) significantly improved progression-free and overall survival in patients with platinum-resistant ovarian cancer in the phase 3 ROSELLA trial, ...

A circulating tumor DNA (ctDNA) blood test demonstrated high sensitivity and specificity for colorectal cancer (CRC) detection in a large average-risk population, study finds.

Developments in artificial intelligence (AI) can help clinicians to diagnose thoracic conditions that may be miss on first glance.

This contributor column discusses a recent study that shows the 340B Program’s explosive growth is overwhelmingly due to ...

Adults with peanut allergy experienced effective treatment with peanut oral immunotherapy but future studies are necessary to ...

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...

Older adults with cardiovascular disease (CVD) or CVD risk factors report that gaps in communication among their providers are common and hazardous.

Panelists discuss the primary access challenges in chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) treatment, including financial barriers and health care system limitations, and how ...

"Political directives should not prevent individuals from seeking safe and effective care that they desire and deserve," ...

US workers facing high economic hardship, especially those in lower-wage occupations, were significantly more likely to ...

Lenacapavir works to both treat and prevent HIV, making it a promising drug should it be approved by the FDA later this month.

Dirk Arnold, MD, PhD, medical director, Asklepios Tumour Biology Centre, discusses a phase 3 clinical trial investigating amivantamab in metastatic colorectal cancer.